Formulation and evaluation of a propanidid hydroxypropyl-β- cyclodextrin solution for intravenous anaesthesia

International Journal of Pharmaceutics

Volumn 159, Issue 2, 1997, Pages 191-196

  MacKenzie, Craig R ^a   Fawcett, J Paul ^a   Boulton, David W ^a   Tucker, Ian G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Anaesthetics; Cyclodextrins; Drug stability; Propanidid; Propofol

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CREMOPHOR; INTRAVENOUS ANESTHETIC AGENT; PROPANIDID; PROPOFOL;

ANALGESIC ACTIVITY; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031574276     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00283-4     Document Type: Article

References (15)

1. Albers E., Müller B.W. Cyclodextrin derivatives in pharmaceutics. CRC Crit. Rev. Therap. Drug Carrier Syst. 12:1995;311-337.
2. Bekers O., Uijtendaal E.V., Beijnen J.H., Bult A., Underberg W.J.M. Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm. 17:1991;1503-1549.
3. Brewster M.E., Estes K.S., Bodor N. Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins. J. Parenter. Sci. Tech. 43:1989;262-265.
4. Brewster M.E., Estes K.S., Bodor N. An intravenous toxicity study of 2-hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and monkeys. Int. J. Pharm. 59:1990;231-243.
5. Brewster M.E., Anderson W.R., Loftsson T., Huang M.J., Bodor N., Pop E. Preparation, characterization and anaesthetic properties of 2-hydroxypropyl-β-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. J. Pharm. Sci. 84:1995;1154-1159.
6. Christmas D. Immune reaction to propanidid. Anaesthesia. 39:1984;470-473.
7. Conway C.M., Ellis D.B. Propanidid Br. J. Anaesth. 42:1970;249-254.
8. Deschodt J., Lubrano J.F., Peschaud J.L., Eledjam J.J., du Cailar J. Comparaison du propofol au propanidid administrés à débit constant. Ann. Fr. Anesth. Réanim. 7:1988;459-463.
9. Doenicke A., Roizen M.F., Nebauer A.E., Kugler A., Hoernecke R., Beger-Hintzen H. A comparison of two formulations for etomidate, 2-hydroxypropyl-β-cyclodextrin (HPCD) and propylene glycol. Anesth. Analg. 79:1994;933-939.
10. Dundee J.W., Clarke R.S.J. Clinical studies of induction agents. IX: A comparative study of a new eugenol derivative, FBA.1420, with G.29.505 and standard barbiturates. Br. J. Anaesth. 36:1964;100-104.
11. Glen J.B., Davis G.E., Thomson D.S., Scarth S.C., Thompson A.V. An animal model for the investigation of adverse responses to I.V. anaesthetic agents and their solvents. Br. J. Anaesth. 51:1979;819-826.
12. Higuchi T., Connors A. Solubility techniques. Adv. Anal. Chem. Instrum. 4:1965;117-211.
13. Howells T.H., Odell J.R., Hawkins T.J., Steane P.A. An introduction to FBA.1420. Br. J. Anaesth. 36:1964;295-301.
14. Nousiainen U., Raatikainen O. High-performance liquid chromatography of propanidid in rat plasma. J. Chromatogr. 308:1984;376-381.
15. Viernstein H., Stumpf L., Spiegl P., Reiter S. Preparation and central action of propofol hydroxyl-β-cyclodextrin complexes in rabbits. Arzneim.-forsch. 43:1993;818-821.